TWO-PB - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 20/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Largely moves in line with the broader market.

Beta (Market Relation)

1.06x

Above average

Volatility (5Y p.a.)

17.3% p.a.

5-Year Horizon

Max Drawdown (5Y)

-36.5%

5-Year Horizon

Sharpe Ratio

-0.18

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+8.3%
3 Years	14.9%	-15.0%	0.39	+8%
5 Years	17.3%	-36.5%	-0.18	-0.5%
10 Years	43.7%	-72.1%	-0.06	—

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 379%.

Unprofitable business model: The company is currently generating net losses.

🔴 High valuation risk: Avg P/E of 46.0 (Elevated multiple compression risk)

Strong cyclicality: The business model is sensitive to economic downturns.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (17.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -72.1% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

Audit Risk

Board Risk

Short Ratio

0.04